Publication | Closed Access
Novel glucagon- and OXM-based peptides acting through glucagon and GLP-1 receptors with body weight reduction and anti-diabetic properties
10
Citations
23
References
2019
Year
Metabolic SyndromeBiochemistryMedicineOxm-based PeptidesDiabetesNon-peptide LigandBody Weight ReductionPharmacologyGlp-1 ReceptorsInsulin SignalingDrug DiscoveryGastrointestinal Peptide Hormone
| Year | Citations | |
|---|---|---|
Page 1
Page 1